ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2965

Targeting Glucose Metabolism in the Murine Air Pouch Model of Acute Gouty Inflammation

Anyan Cheng1, Roxana Coras1,2, Robert Terkeltaub3,4, Ru Liu-Bryan1,3 and Monica Guma1,2, 1Medicine, University of California San Diego, La Jolla, CA, 2Medicine, Autonomous University of Barcelona, Bellatera, Spain, 3VA San Diego Healthcare System, San Diego, CA, 4Medicine, Division of Rheumatology, Allergy and Immunology. UCSD., La Jolla, CA

Meeting: 2018 ACR/ARHP Annual Meeting

Keywords: gout, IL-1, inflammasome activation and uric acid, Macrophage

  • Tweet
  • Email
  • Print
Session Information

Date: Wednesday, October 24, 2018

Title: 6W020 ACR Abstract: Metabolic & Crystal Arthropathies–Basic Science & Imaging (2964–2969)

Session Type: ACR Concurrent Abstract Session

Session Time: 11:00AM-12:30PM

Background/Purpose: Emerging evidence indicates that macrophage activation is critically supported by glucose metabolic shifts. Although macrophages are key contributors to inflammation, little is known about the role of glucose metabolism in the pathogenesis of inflammatory gouty arthritis. Thus, we evaluated glucose metabolism in the murine air-pouch model of acute gouty inflammation.

Methods: Mice (N=6 in each group) were injected with PBS or 3-bromopyruvate (BrPa; 7.5 mg/kg) 1 hour before MSU injection to assess the effect of glycolysis inhibition in vivo. After 6 hours injection of monosodium urate (MSU) crystals (3 mg/ml) in the air pouch, both the air pouch lavage and peripheral blood were collected. The infiltrating leukocytes obtained from the lavage after centrifugation and peripheral blood mononuclear cells (PBMCs) isolated from the blood were subjected to quantitative RT-PCR for expression of glycolysis-related genes Glut1 and LDHa, and NLRP3 inflammasome-related genes IL-1band NLRP3. Production of IL-1b, CXCL1 and IL-6 were quantified from supernatant of the lavage by ELISA analysis. The air-pouch tissues were also collected and fixed, and subsequently H&E staining was performed. For ex vivostudies, thioglycolate-elicited peritoneal macrophages were collected and stimulated with LPS (100 ng/ml for four hours) and MSU (0.2 mg/ml overnight) with and without pretreatment of 2-deoxy-glucose (2DG, 10mM), another glycolysis inhibitor, for one hour. Expression of glycolysis-related genes and cytokine production were assessed from the cells and conditioned media, respectively, using the methods mentioned above.

Results: MSU crystals promoted glycolysis in both infiltrating leukocytes and PBMCs, evidenced by increased expression of Glut1 and LDHa. This was associated with upregulation of gene expression of IL-1band NLRP3 in both PBMC and air-pouch elicited cells. BrPa significantly lowered numbers of infiltrating leukocytes (3.26±0.79×106 vs 0.74±0.1×106,±p<0.01, in the MSU group after PBS or BrPa respectively) and the amount of proinflammatory cytokines CXCL1 (2379±620 vs 992±255 pg/ml, p<0.05), IL-1b(429.6±140.7 vs 103.3±12 pg/ml, p=0.02), and IL-6 (2111±418 vs 865±236 pg/ml) in the air pouch. It also markedly reduced leukocyte infiltration in the air pouch lining in response to MSU crystals (3±0.66 vs 1±0.57, p=0.012 in PBS or BrPa-treated mice respectively). Treatment with 2-DG in peritoneal macrophages significantly inhibited gene expression of Glut 1, hexokinase 2 (HK2), and LDHa, and production of CXCL1, IL-1b, IL-6, and TNF after LPS and/or MSU stimulation.

Conclusion: Glycolytic inhibition could attenuate MSU crystal-induced inflammatory response. Targeting metabolic dysfunction could be a novel treatment strategy for acute gouty arthritis.


Disclosure: A. Cheng, None; R. Coras, None; R. Terkeltaub, None; R. Liu-Bryan, None; M. Guma, None.

To cite this abstract in AMA style:

Cheng A, Coras R, Terkeltaub R, Liu-Bryan R, Guma M. Targeting Glucose Metabolism in the Murine Air Pouch Model of Acute Gouty Inflammation [abstract]. Arthritis Rheumatol. 2018; 70 (suppl 9). https://acrabstracts.org/abstract/targeting-glucose-metabolism-in-the-murine-air-pouch-model-of-acute-gouty-inflammation/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2018 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/targeting-glucose-metabolism-in-the-murine-air-pouch-model-of-acute-gouty-inflammation/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology